As of 2026-01-02, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is
-4.22.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value
is 91.73 mil USD. MEIP's TTM EBITDA according to its financial statements is
-21.71 mil USD. Dividing these 2
quantities gives us the above MEIP EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
15.3x - 15.4x |
15.4x |
| Forward P/E multiples |
22.1x - 35.3x |
22.3x |
| Fair Price |
(11.10) - 18.42 |
0.23 |
| Upside |
-461.7% - 499.9% |
-92.6% |